Sun, 07 Jun 2015 21:47:04 GMT ~ Ligand Announces Favorable Results From Phase 1b Trial With LGD-6972 in Type 2 Diabetes and Plans to Initiate a Phase 2 Trial
[at noodls] - Presentation at the American Diabetes Association 75th Scientific Sessions SAN DIEGO--(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces results from a Phase 1b clinical trial ...
Sun, 07 Jun 2015 21:30:00 GMT ~ Ligand Announces Favorable Results From Phase 1b Trial With LGD-6972 in Type 2 Diabetes and Plans to Initiate a Phase 2 Trial
[Business Wire] - Ligand Pharmaceuticals Incorporated announces results from a Phase 1b clinical trial with LGD-6972 that demonstrate favorable safety, tolerability and pharmacokinetics in normal healthy volunteers and in subjects with type 2 diabetes mellitus.
Fri, 05 Jun 2015 21:04:02 GMT ~ Ligand Announces New Time for June 7th Investor Presentation and Webcast at the American Diabetes Association 75th Scientific Sessions
[at noodls] - SAN DIEGO--(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that the start time for the previously announced investor presentation on Sunday, June 7th is now 6 p.m. Eastern ...
Link: http://www.otcmarkets.com/stock/LGND/company-info Ticker: $LGND OTC Market Place: Not Available CIK code: 0000886163 Company name: Ligand Pharmaceuticals Incorporated Company website: http://www.ligand.com Incorporated In: DE, USA
Business Description: Ligand discovers, develops and markets new drugs for critical unmet medical needs in the areas of cancer, pain, skin diseases, hormone-related diseases, osteoporosis, metabolic disorders, cardiovascular and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology related to intracellular receptors.
$LGND share structure
## source: otcmarkets.com
Market Value: $1,827,040,889 a/o Jun 09, 2015 Shares Outstanding: 19,666,748 a/o May 01, 2015 Float: Not Available Authorized Shares: Not Available Par Value: 0.001
$LGND extra dd links
Company name: Ligand Pharmaceuticals Incorporated Company website: http://www.ligand.com